BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35811408)

  • 1. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting.
    Hirsch S; Nurko S; Liu E; Rosen R
    Neurogastroenterol Motil; 2022 Nov; 34(11):e14428. PubMed ID: 35811408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapyloric Botulinum Toxin Injection for Refractory Nausea and Vomiting in Pediatric Patients.
    Osgood PT; Essner BS; Fountain L; Sullivan EC; Meegan C; Fortunato JE
    J Pediatr Gastroenterol Nutr; 2023 Dec; 77(6):726-733. PubMed ID: 37794574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.
    Rodriguez L; Rosen R; Manfredi M; Nurko S
    Gastrointest Endosc; 2012 Feb; 75(2):302-9. PubMed ID: 22248598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the pylorus with concurrent intraluminal pressure and EndoFLIP in patients with nausea and vomiting.
    Snape WJ; Lin MS; Agarwal N; Shaw RE
    Neurogastroenterol Motil; 2016 May; 28(5):758-64. PubMed ID: 26813266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children.
    Hirsch S; Nurko S; Mitchell P; Rosen R
    J Pediatr; 2020 Nov; 226():228-235. PubMed ID: 32599032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyloric sphincter characteristics using EndoFLIP
    Saadi M; Yu D; Malik Z; Parkman HP; Schey R
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(4):375-384. PubMed ID: 29709494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EndoFLIP assessment of pyloric sphincter in children: a single-center experience.
    Popescu M; White E; Mutalib M
    Transl Gastroenterol Hepatol; 2023; 8():17. PubMed ID: 37197257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyloric distensibility measurement predicts symptomatic response to intrapyloric botulinum toxin injection.
    Desprez C; Melchior C; Wuestenberghs F; Zalar A; Jacques J; Leroi AM; Gourcerol G
    Gastrointest Endosc; 2019 Nov; 90(5):754-760.e1. PubMed ID: 31028783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapyloric botulinum toxin injection for functional nausea and vomiting: Just a placebo?
    Bolia R
    Neurogastroenterol Motil; 2022 Dec; 34(12):e14479. PubMed ID: 36194187
    [No Abstract]   [Full Text] [Related]  

  • 10. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis.
    Bromer MQ; Friedenberg F; Miller LS; Fisher RS; Swartz K; Parkman HP
    Gastrointest Endosc; 2005 Jun; 61(7):833-9. PubMed ID: 15933684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endoscopic pyloric therapies for patients with nausea and vomiting and functional obstructive gastroparesis.
    Wellington J; Scott B; Kundu S; Stuart P; Koch KL
    Auton Neurosci; 2017 Jan; 202():56-61. PubMed ID: 27460691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gastric per-oral endoscopic myotomy on static and dynamic pyloric function in gastroparesis patients.
    Watts LS; Baker JR; Lee AA; Harer K; Bowers N; Law R; Hasler WL
    Neurogastroenterol Motil; 2020 Nov; 32(11):e13892. PubMed ID: 32542920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing pyloric sphincter pathophysiology using EndoFLIP in patients with gastroparesis.
    Malik Z; Sankineni A; Parkman HP
    Neurogastroenterol Motil; 2015 Apr; 27(4):524-31. PubMed ID: 25712043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New therapeutic approaches to diabetic gastroparesis].
    Hummel M; Geigenberger G; Brand J; Ziegler AG; Füchtenbusch M
    Med Klin (Munich); 2008 Jul; 103(7):514-8. PubMed ID: 18604486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EndoFLIP and Pyloric Dilation for Gastroparesis Symptoms Refractory to Pyloromyotomy/Pyloroplasty.
    Jehangir A; Malik Z; Petrov RV; Parkman HP
    Dig Dis Sci; 2021 Aug; 66(8):2682-2690. PubMed ID: 32749636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients.
    Arts J; van Gool S; Caenepeel P; Verbeke K; Janssens J; Tack J
    Aliment Pharmacol Ther; 2006 Aug; 24(4):661-7. PubMed ID: 16907899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric electrical stimulation: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(16):1-79. PubMed ID: 23074486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of delayed gastric emptying after esophagectomy: a single center's experience with botulinum toxin.
    Martin JT; Federico JA; McKelvey AA; Kent MS; Fabian T
    Ann Thorac Surg; 2009 Jun; 87(6):1708-13; discussion 1713-4. PubMed ID: 19463583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric electrical stimulation for children with intractable nausea and gastroparesis.
    Islam S; Vick LR; Runnels MJ; Gosche JR; Abell T
    J Pediatr Surg; 2008 Mar; 43(3):437-42. PubMed ID: 18358278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus.
    Lacy BE; Crowell MD; Schettler-Duncan A; Mathis C; Pasricha PJ
    Diabetes Care; 2004 Oct; 27(10):2341-7. PubMed ID: 15451898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.